Non-Standard Steps to Take Against Cancer

Table of Contents: Select a Link to be Taken to That Section

Executive Summary

  • Several steps to take against cancer do not involve the standard treatments offered by the medical establishment.

Introduction

This article provides an explanation and links to the non-standard steps for cancer.

Step #1: Ivermectin

Ivermectin is one of the top non-standard drugs for cancer. The dosage recommendations are found in the following The Brightwork Ivermectin Dosage Guide. One of the many things hidden from the public by the medical establishment How Many Mechanisms Does Ivermectin Fight Cancer.

Now, Ivermectin is not approved for cancer by the FDA. However, numerous articles on the site explain that it is available as an anti-parasitical. While taking it as an anti-parasitical, one is allowed to get the cancer-fighting benefits of Ivermectin. I take Ivermectin for many reasons, but I also know from reading a great deal of research that it reduces my likelihood and the likelihood of anyone who takes it from getting cancer.

We receive questions about whether there is a specific dosage for cancer or for types of cancer, which is answered in the article Is There a Best Ivermectin Dosage for Cancer or Cancer Types?

Step #2: Cancer and the Immune System

The medical establishment generally only discusses the immune system concerning cancer when it can direct patients to high-cost pharmaceutical options that fall under the immunotherapy category.

Outside of that, the medical establishment is mostly silent on the importance of the immune system in combating cancer. Oncologists usually dissuade patients from taking things that will improve their immune system because it might negatively interact with their treatment. They also don’t focus on exercise, a crucial part of enhancing the immune system. When speaking with one cancer patient, I was told that he only talks to his oncologist about “cancer stuff” and not exercise, which is not part of cancer stuff. This is genuinely how oncologists think.